KLOW
SKU：klow-blend
Price：USD 100.00
Product information
KLOW is a multi-peptide blend freeze-dried into an 80 mg vial for comparative multi-pathway research. Individual ingredient studies concern collagen, inflammatory signalling, angiogenesis and cell structure. Studying several conditions together differs from examining each compound alone. Those separate research themes do not establish the efficacy or clinical activity of the complete formulation.
Product specifications
- Product Type
- Four-peptide research blend
- Component 1
- GHK-Cu 50 mg - copper-binding tripeptide
- Component 2
- TB-500 10 mg - thymosin β-4 fragment
- Component 3
- BPC-157 10 mg - gastric pentadecapeptide
- Component 4
- KPV 10 mg - α-MSH C-terminal tripeptide
- Total Peptide Content
- 80 mg per vial
- Form
- Lyophilized powder
- Purity
- ≥99% (HPLC verified)
- Testing
- Third-party HPLC, Mass Spec, Endotoxin
- Storage
- -20°C for long-term stability
- Label amount
- 80mg
Analysis report
KLOW 80mg · 80mg · KLOW-101926-80
KLOW 80mg · 80mg · KL-09282026-80
KLOW 80mg · 80mg · KL-09282026-80
Klow 80 mg · 80mg · Not provided
Klow 80mg · 80mg · KL-090226-80
GHKCu 50mg + TB-500 10mg + BPC-157 10mg + KPV 10mg (KLOW) · 80mg · RXY8XM
GHKCu 50mg + TB-500 10mg + BPC-157 10mg + KPV 10mg (KLOW) · 80mg · S7UDXN
KLOW 80mg · 80mg · XX1EZC
Certificate of Analysis · Not provided · Not provided
Certificate of Analysis · Not provided · Not provided
Certificate of Analysis · Not provided · KLOW-032026-4
GHKCu 50mg + TB-500 10mg + BPC-157 10mg + KPV 10mg (KLOW) · 50mg · KLOW-032026-1
Research information
Read the full KLOW research monograph
Research overview
KLOW is a multi-peptide blend freeze-dried into an 80 mg vial for comparative multi-pathway research. Individual ingredient studies concern collagen, inflammatory signalling, angiogenesis and cell structure. Studying several conditions together differs from examining each compound alone. Those separate research themes do not establish the efficacy or clinical activity of the complete formulation.